Scientific opinion on the substantiation of health claims related to galacto-oligosaccharides (GOS)
This opinion addressed the scientific substantiation of health claims in relation to galacto-oligosaccharides (GOS) and reduction of gastro-intestinal discomfort and decreasing potentially pathogenic microorganisms.
This opinion addresses the scientific substantiation of health claims in relation to galacto-oligosaccharides amd reduction of gastro-intestinal discomfort and decreasing potentially pathogenic microorganisms.
Link to Publication: http://www.efsa.europa.eu/en/efsajournal/doc/2060.pdf
WYE-EM-233-JUL-15
Reference
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of health claims related to galacto-oligosaccharides (GOS) and reduction of gastro-intestinal discomfort (ID763) and decreasing potentially pathogenic microorganisms (ID 765) pursuant to Article 13(1) of Regulation (EC) No1924/2006. EFSA Journal 2011;9(4):2060. doi:10.2903/j.efsa.2011.2060.